109 related articles for article (PubMed ID: 15672606)
21. Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein.
Legros Y; Lafon C; Soussi T
Oncogene; 1994 Jul; 9(7):2071-6. PubMed ID: 8208553
[TBL] [Abstract][Full Text] [Related]
22. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.
Vojtĕsek B; Bártek J; Midgley CA; Lane DP
J Immunol Methods; 1992 Jul; 151(1-2):237-44. PubMed ID: 1378473
[TBL] [Abstract][Full Text] [Related]
23. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
Koch C; Whitechurch O; Cordier P; Roitsch C
Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
[TBL] [Abstract][Full Text] [Related]
24. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
25. Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.
Paley EL; Smelyanski L; Malinovskii V; Subbarayan PR; Berdichevsky Y; Posternak N; Gershoni JM; Sokolova O; Denisova G
Mol Immunol; 2007 Jan; 44(4):541-57. PubMed ID: 16616781
[TBL] [Abstract][Full Text] [Related]
26. Epitope analysis of the murine p53 tumour suppressor protein.
Lane DP; Stephen CW; Midgley CA; Sparks A; Hupp TR; Daniels DA; Greaves R; Reid A; Vojtesek B; Picksley SM
Oncogene; 1996 Jun; 12(11):2461-6. PubMed ID: 8649788
[TBL] [Abstract][Full Text] [Related]
27. Distinct conformations of p53 are observed at different stages of keratinocyte differentiation.
Spandau DF
Oncogene; 1994 Jul; 9(7):1861-8. PubMed ID: 7516060
[TBL] [Abstract][Full Text] [Related]
28. Structural immuno-analysis of human and porcine interferon gamma: identification of shared antigenic domain.
Kontsek P; Martens E; Vandenbroeck K; Kontseková E; Waschütza G; Sareneva T; Billiau A
Cytokine; 1997 Aug; 9(8):550-5. PubMed ID: 9245481
[TBL] [Abstract][Full Text] [Related]
29. A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
Chrétien I; Helm BA; Marsh PJ; Padlan EA; Wijdenes J; Banchereau J
J Immunol; 1988 Nov; 141(9):3128-34. PubMed ID: 2459242
[TBL] [Abstract][Full Text] [Related]
30. Comparison of anti-p53 antibodies in immunoblotting.
Turpeinen M; Serpi R; Rahkolin M; Vähäkangas K
Biochem Biophys Res Commun; 2002 May; 293(2):850-6. PubMed ID: 12054549
[TBL] [Abstract][Full Text] [Related]
31. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
[TBL] [Abstract][Full Text] [Related]
32. Generation of monospecific peptide antibodies to the DNA binding domain of p53.
Huppi K; Henderson D; Siwarski D; Hochman J; Bergel M; Tuchscherer G
Biotechniques; 2000 Nov; 29(5):1100-6. PubMed ID: 11084873
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein.
Bessard AC; Garay E; Lacronique V; Legros Y; Demarquay C; Houque A; Portefaix JM; Granier C; Soussi T
Oncogene; 1998 Feb; 16(7):883-90. PubMed ID: 9484779
[TBL] [Abstract][Full Text] [Related]
34. The effect of phosphorylation on the antigenic reactivity of p53 in cultured human keratinocytes.
Kumar M; Spandau DF
Biochem Biophys Res Commun; 1995 Sep; 214(2):744-53. PubMed ID: 7545906
[TBL] [Abstract][Full Text] [Related]
35. Analysis of epitopes of mouse monoclonal antibodies against human alpha-fetoprotein.
Kang Y; Matsuura E; Sakamoto T; Sakai M; Nishi S
Tumour Biol; 2001; 22(4):254-61. PubMed ID: 11399951
[TBL] [Abstract][Full Text] [Related]
36. Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein NCp7 and its precursor NCp15 as detected by anti-NCp7 monoclonal antibodies.
Tanchou V; Delaunay T; Bodéus M; Roques B; Darlix JL; Benarous R
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2457-66. PubMed ID: 7595349
[TBL] [Abstract][Full Text] [Related]
37. Latex-agglutination analysis of human recombinant interleukin-2 with monoclonal antibodies.
Lunev VE; Lukin YuV ; Kazennykh NV; Belyaev SV; Zubov VP; Nesmeyanov VA
Biomed Sci; 1990 Jan; 1(1):68-72. PubMed ID: 1718463
[TBL] [Abstract][Full Text] [Related]
38. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.
Enjoh T; Hizuka N; Perdue JF; Takano K; Fujiwara H; Higashihashi N; Marumoto Y; Fukuda I; Sakano K
J Clin Endocrinol Metab; 1993 Aug; 77(2):510-7. PubMed ID: 7688378
[TBL] [Abstract][Full Text] [Related]
39. A panel of monoclonal antibodies to rat plectin: distinction by epitope mapping and immunoreactivity with different tissues and cell lines.
Foisner R; Feldman B; Sander L; Seifert G; Artlieb U; Wiche G
Acta Histochem; 1994 Dec; 96(4):421-38. PubMed ID: 7717046
[TBL] [Abstract][Full Text] [Related]
40. Anti-U1A monoclonal antibodies recognize unique epitope targets of U1A which are involved in the binding of U1 RNA.
Lutz CS; McClain MT; Harley JB; James JA
J Mol Recognit; 2002; 15(3):163-70. PubMed ID: 12203842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
